tissue plasminogen activator
Therefore, we proposed to use data from the National Institute of Neurological       Disorders and Stroke (NINDS) tPA Stroke Trial to determine whether the National       Institutes of Health Stroke Scale (NIHSS) was valid in patients treated with       tissue plasminogen activator (tPA) and to explore the underlying clinimetric       structure of the NIHSS.
Therefore, we proposed to use data from the National Institute of Neurological       Disorders and Stroke (NINDS) tPA Stroke Trial to determine whether the National       Institutes of Health Stroke Scale (NIHSS) was valid in  @OBJECT$   @PREDICAT$  with        @SUBJECT$  (tPA) and to explore the underlying clinimetric       structure of the NIHSS.